TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (the "Company"), an oncology company integrating novel delivery technology with standard of care therapies, and its investigational immunotherapeutic to ...
Contract Research Organization for the Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML) Informed the Company that 78 Events have Occurred in the Trial as of May 11, ...
Life sciences real estate is still under major pressure. Behind rows of unused microscopes, falling rents and anxious ...
A senior SOG official said the ‘guess’ paper leaked from a printing press in Nashik, and was used in Haryana or Rajasthan ...
Grant program expands access to advanced single-domain antibody technologies to support the research and development of next-generation therapies ...
The consensus estimate for Q1 2026 revenue is $10.44 million, and the earnings are expected to come in at -$0.16 per share. The full year 2026's revenue is expected to be $59.96 million and the ...
Christopher Martin joins the Board of Directors, with Mark Zappia and Jim Willis joining as Senior Vice President of ...
Quinnipiac will host its Commencement ceremony for the College of Arts & Sciences and School of Communications on Saturday, ...
China behind only US and UK in ranking, reflecting the country’s ‘major scale’ in AI, biotechnology and talent, says Deep ...
Colorado State University economics professor Ed Barbier was elected last month to the National Academy of Sciences.
The University of Wyoming College of Arts and Sciences recently held its annual awards banquet, honoring current and former ...
Life sciences executives are confronting a pivotal juncture in commercial strategy. The pharmaceutical and medical technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results